FDA official logo
GSRS logo
PFDA official logo

DOLUTEGRAVIR SODIUM

  • UNII: 1Q1V9V5WYQ
  • Formula: C20H18F2N3O5.Na
  • Preferred Substance Name: DOLUTEGRAVIR SODIUM
  • InChIKey: UGWJRRXTMKRYNK-VSLILLSYSA-M

  • 1051375-19-9
  • 2H-PYRIDO(1',2':4,5)PYRAZINO(2,1-B)(1,3)OXAZINE-9-CARBOXAMIDE, N-((2,4-DIFLUOROPHENYL)METHYL)-3,4,6,8,12,12A-HEXAHYDRO-7-HYDROXY-4-METHYL-6,8-DIOXO-, SODIUM SALT (1:1), (4R,12AS)-
  • DOLUTEGRAVIR SODIUM [JAN]
  • DOLUTEGRAVIR SODIUM [ORANGE BOOK]
  • DOLUTEGRAVIR SODIUM [USAN]
  • DOLUTEGRAVIR SODIUM [WHO-DD]
  • DOLUTEGRAVIR SODIUM COMPONENT OF JULUCA
  • DOLUTEGRAVIR SODIUM COMPONENT OF TRIUMEQ
  • DOLUTEGRAVIR SODIUM SALT [MI]
  • DOVATO
  • GSK-1349572A
  • JULUCA COMPONENT DOLUTEGRAVIR SODIUM
  • SODIUM (4R,12AS)-9-(((2,4-DIFLUOROPHENYL)METHYL)CARBAMOYL)-4-METHYL-6,8-DIOXO-3,4,6,8,12,12A-HEXAHYDRO-2H-PYRIDO(1',2':4,5)PYRAZINO(2,1-B)(1,3)OXAZIN-7-OLATE
  • TIVICAY
  • TIVICAY PD
  • TRIUMEQ COMPONENT DOLUTEGRAVIR SODIUM

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.